目的探讨转染血管内皮生长因子(VEGF)基因的小鼠NIH3T3细胞移植对缺血皮瓣的血管新生和皮瓣存活率的影响。方法体外PcDNA3.1(-)/VEGF165质粒转染小鼠NIH3T3细胞,免疫组化方法检测小鼠NIH3T3细胞体外表达VEGF的情况,CM-DiI标记小鼠NIH3T3细胞。将小鼠随机分为3组:A组[PcDNA3.1(-)/VEGF165质粒转染的NIH3T3细胞移植]、B组(单纯NIH3T3细胞移植)、C组(单纯DMEM培养基注射)。每只小鼠背侧皮下按组分别注射细胞悬液和培养基,注射后酶联免疫吸附(ELISA)法连续检测大鼠血浆VEGF浓度,注射后第4天掀起一个蒂在尾侧的4.0cm×1.5cm的随意皮瓣。术后第7天分别观察皮瓣的存活率、血流灌注、皮瓣毛细血管密度、NIH3T3细胞在皮瓣内的分布和存活情况。结果转染VEGF165基因的小鼠NIH3T3细胞体外和体内检测均高表达VEGF165蛋白。A组的皮瓣存活率、毛细血管密度、血流灌注比值均显著高于另外两组(P〈0.05)。结论转染VEGF基因的小鼠NIH3T3细胞皮下移植可促进缺血皮瓣的血管新生,提高存活率。
Objective To investigate the feasibility of applying NIH3T3 cells transfected by VEGF gene to the treatment of ischemic random skin flaps. Methods Plasmid PcDNA3. 1 ( - )/VEGF165 containing VEGF gene was transduced into the mouse NIH3T3 cells by liposome. Immunohistochemistry was used to detect the expression of VEGF protein of mouse NIH/3T3 cells in vitro. The NIH3T3 cells were stained with CM-DiI before the transplantation. Thirty mice were randomized into 3 groups: Groups A, B and C, and were respectively injected with NIH/3T3 cells tansfected with PeDNA3. 1 ( - )/VEGF165 plasmid, NIH/3T3 cells and medium only. On the 4th day after the injection, random dorsal skin flaps with an area of 4. 0 cm × 1.5 cm were established. The survival, neovasculariztion and blood flow recovery of the flaps were detected. Results VEGF-transduced NIH3T3 cells expressed VEGF highly in vitro and in vivo. The results showed that flap survival rate in group A ( 95. 1% ± 3. 1% ) was significantly higher than those in group B (37. 4% ± 6. 3% ) and group C (26. 2% ± 5.6% ). The capillary density and the blood perfusion of the flaps in group A were significantly higher than those in other two groups. Condusions VEGF- transfected NIH3T3 cells can improve ischemic flap neovascularization and extend survival areas.